chevron_leftBack
As of 10 June 2026, J. Molner AS has a market cap of $39.26M USD, ranking #32293 globally and #14 in Estonia.
It ranks #2920 in the Healthcare sector, and #1009 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$39.26MUSD
34.06M EUR
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
2015
Website
jmolner.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.7% | 5% | -11% | -22% | -19% | -4.5% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MOLNR
J.Molner AS
ISIN: EE3100109034
Shares Out.:
Shares Outstanding:
1.686M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
20.20 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About J. Molner AS
J. Molner AS, a pharmaceutical company, focuses on the development and manufacturing of generic medicines in the United States, Canada, and Europe. The company develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs. It also offers drug development, analytical chemistry, and stability testing services. The company was founded in 2015 and is based in Tallinn, Estonia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
918K%
|
97.4
|
|
SIX: RO
|
$321.17B
818K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
732K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
699K%
218.9B CHF
|
20.5
|
chevron_leftBack